ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1-Hydroxybenzotriazole → Oritavancin

HRID 1397132
ノート
印刷プレビュー

反応式

HRID 1397132 の反応式
[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@@H:9]2[C:113]3[CH:114]=[CH:115][C:110](=[C:111]([Cl:116])[CH:112]=3)[O:109][C:37]3=[C:38]([O:73][C@@H:74]4[O:79][C@H:78]([CH2:80][OH:81])[C@@H:77]([OH:82])[C@H:76]([OH:83])[C@H:75]4[O:84][C@@H:85]4[O:90][C@@H:89]([CH3:91])[C@H:88]([OH:92])[C@:87]([NH:94][CH2:95][C:96]5[CH:101]=[CH:100][C:99]([C:102]6[CH:107]=[CH:106][C:105]([Cl:108])=[CH:104][CH:103]=6)=[CH:98][CH:97]=5)([CH3:93])[CH2:86]4)[C:39]4[O:41][C:42]5[CH:47]=[CH:46][C:45]([C@@H:48]([OH:71])[C@@H:49]([NH:61][C:62]([C@H:64]([NH:69][CH3:70])[CH2:65][CH:66]([CH3:68])[CH3:67])=[O:63])[C:50]([NH:52][C@@H:53]([CH2:57][C:58]([NH2:60])=[O:59])[C:54]([NH:56][C@H:34]([C:35]([CH:40]=4)=[CH:36]3)[C:32](=[O:33])[NH:31][C@H:27]3[C:28]([NH:30][C@@H:10]2[C:11]([NH:13][C@H:14]([C:120]([OH:122])=[O:121])[C:15]2[C:20]([C:21]4[CH:26]=[C:25]3[CH:24]=[CH:23][C:22]=4[OH:117])=[C:19]([OH:118])[CH:18]=[C:17]([OH:119])[CH:16]=2)=[O:12])=[O:29])=[O:55])=[O:51])=[CH:44][C:43]=5[Cl:72])[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125].OP(O)(O)=O.OP(O)(O)=O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.CN(C)CCN(C)C(=O)CO>CS(C)=O.CN(C=O)C.C(OCC)C>[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@H:9]2[C@@H:10]3[NH:30][C:28](=[O:29])[C@@H:27]([C:25]4[CH:24]=[CH:23][C:22]([OH:117])=[C:21]([C:20]5[C:19]([OH:118])=[CH:18][C:17]([OH:119])=[CH:16][C:15]=5[C@@H:14]([C:120]([OH:122])=[O:121])[NH:13][C:11]3=[O:12])[CH:26]=4)[NH:31][C:32](=[O:33])[C@H:34]3[C:35]4=[CH:40][C:39]([O:41][C:42]5[CH:47]=[CH:46][C:45]([C@@H:48]([OH:71])[C@@H:49]([NH:61][C:62]([C@H:64]([NH:69][CH3:70])[CH2:65][CH:66]([CH3:67])[CH3:68])=[O:63])[C:50]([NH:52][C@@H:53]([CH2:57][C:58]([NH2:60])=[O:59])[C:54]([NH:56]3)=[O:55])=[O:51])=[CH:44][C:43]=5[Cl:72])=[C:38]([O:73][C@@H:74]3[O:79][C@H:78]([CH2:80][OH:81])[C@@H:77]([OH:82])[C@H:76]([OH:83])[C@H:75]3[O:84][C@@H:85]3[O:90][C@@H:89]([CH3:91])[C@H:88]([OH:92])[C@:87]([NH:94][CH2:95][C:96]5[CH:97]=[CH:98][C:99]([C:102]6[CH:103]=[CH:104][C:105]([Cl:108])=[CH:106][CH:107]=6)=[CH:100][CH:101]=5)([CH3:93])[CH2:86]3)[C:37](=[CH:36]4)[O:109][C:110]3=[C:111]([Cl:116])[CH:112]=[C:113]2[CH:114]=[CH:115]3)[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125]
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 5

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 53297457Oritavancin DiphosphateHCID 54488530N-(2-(Dimethylamino)ethyl)-2-Hydroxy-N-methylacetamide

生成物 1

HCID 16136912Oritavancin

試薬・触媒・溶媒 3

HCID 679Dimethyl Sulfoxide溶媒HCID 3283Diethyl Ether溶媒HCID 6228Dimethylformamide溶媒2 回

実験手順

Oritavancin diphosphate 5 (630.7 mg, 0.3171 mmol), HBTU (601.1 mg, 1.585 mmol) and HOBt (173.4 mg, 1.283 mmol) was dissolved in the mixture of DMSO (4 mL) and DMF (8 mL) and 0.4 mL (2.296 mmol) of DIPEA was added. After stirring at room temperature for 30 min, the solution of 102 in 1 mL DMF was added plus 1 mL rinse. A yellow clear solution was obtained. After 2 days, 250 mL of diethyl ether was added to the reaction while stirring. After stand for a few min, the clear solution was decanted. The process was repeated with another 150 mL of diethyl ether. The residual mixture was dried in vacuo. The product was purified on repetitive C18 flash columns on a Biotage automatic chromatography system with gradient elution of H3PO4 (30 mM)-triethylamine (20 mM) buffer (aq, pH3)/methanol and then C18 column on Biotage system with gradient elution of 0.1% formic acid buffer (aq, pH2)/methanol. The purified product is a white solid as penta-formate salt (43.2 mg, 6%): ESI-MS calculated for C93H111Cl3N12O27: calculated 484.8 (M/4+H), 646.1 (M/3+H), 967.6 (M/2+H). found: 484.6, 646.0, 967.6.

後処理

  1. additionwas added
  2. washrinse
  3. customA yellow clear solution was obtained
  4. waitAfter 2 days
  5. stirringwhile stirring
  6. customAfter stand for a few min, the clear solution was decanted
  7. customThe residual mixture was dried in vacuo
  8. customThe product was purified on repetitive C18 flash columns on a Biotage automatic chromatography system with gradient elution of H3PO4 (30 mM)-triethylamine (20 mM) buffer (aq, pH3)/methanol
  9. washC18 column on Biotage system with gradient elution of 0.1% formic acid buffer (aq, pH2)/methanol

出典と根拠

ORDレコード
ord-c6f2724223b84a21bfe9883bcfe2c70a
出典データセット
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08901072B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート